Rockwell Medical (RMTI) Cash from Operations Growth (5y) (2015 - 2026)
Rockwell Medical (RMTI) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 29.13 Mn | 5.24 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.26% |
| Dec 31, 2025 | 17.74% |
| Sep 30, 2025 | 22.78% |
| Jun 30, 2025 | 17.04% |
| Mar 31, 2025 | 11.81% |
| Dec 31, 2024 | 16.69% |
| Sep 30, 2024 | 21.91% |
| Jun 30, 2024 | 16.43% |
| Mar 31, 2024 | 15.19% |
| Dec 31, 2023 | 62.48% |
| Sep 30, 2023 | 4.72% |
| Jun 30, 2023 | 19.82% |
| Mar 31, 2023 | 3.40% |
| Dec 31, 2022 | 52.86% |
| Sep 30, 2022 | 23.42% |
| Jun 30, 2022 | 3.46% |
| Mar 31, 2022 | -14.08% |
| Dec 31, 2021 | -79.79% |
| Sep 30, 2021 | -1.11% |
| Jun 30, 2021 | 1.14% |